Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience

BACKGROUND: Antiviral drugs are administered in patients with severe COVID‐19 respiratory syndrome, including those treated with direct oral anticoagulants (DOACs). Concomitant administration of antiviral agents has the potential to increase their plasma concentration. A series of patients managed i...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Thromb Haemost
Главные авторы: Testa, Sophie, Prandoni, Paolo, Paoletti, Oriana, Morandini, Rossella, Tala, Maurizio, Dellanoce, Claudia, Giorgi‐Pierfranceschi, Matteo, Betti, Monia, Danzi, Gian Battista, Pan, Angelo, Palareti, Gualtiero
Формат: Artigo
Язык:Inglês
Опубликовано: International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264501/
https://ncbi.nlm.nih.gov/pubmed/32329231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14871
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы